[Long-term therapy of bronchial asthma with ketotifen. European experiences].
The results of clinical trials in patients with allergic bronchial asthma performed to demonstrate the therapeutic effect of the newly developed substance Ketotifen are reviewed: 1. In 154 patients the efficacy of ketotifen was superior to the antihistaminic clemastine. 2. The therapeutic value of ketotifen was similar to that of cromoglycate. 3. Ketotifen is a beneficial substance for long-term treatment of bronchial asthma. The main advantage of ketotifen is its prophylactic effect when given orally.
D000284:Administration, Oral; D000328:Adult; D001249:Asthma / Q000188:drug therapy*; D002648:Child; D004205:Cromolyn Sodium / Q000627:therapeutic use; D004334:Drug Administration Schedule; D004341:Drug Evaluation; D004361:Drug Tolerance; D006634:Histamine H1 Antagonists; D006801:Humans; D007665:Ketotifen; D010880:Piperidines / Q000627:therapeutic use*; D013876:Thiophenes / Q000008:administration & dosage / Q000627:therapeutic use*
D006634:Histamine H1 Antagonists; D010880:Piperidines; D013876:Thiophenes; D004205:Cromolyn Sodium; D007665:Ketotifen
Langzeittherapie des Asthma bronchiale mit Ketotifen Europäische Erfahrungen.